Welcome to our dedicated page for Semler Scientific SEC filings (Ticker: SMLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QuantaFlo® device sales on one page, fair-value bitcoin gains on the next—Semler Scientific’s disclosures can feel like two different companies inside a single filing. Whether you are combing through a Semler Scientific quarterly earnings report 10-Q filing for unit volumes or hunting the note that explains recent crypto purchases, deciphering hundreds of pages is tough. This page delivers Semler Scientific SEC filings explained simply so you can stop scrolling and start understanding.
Stock Titan’s AI reads every submission the moment it hits EDGAR and turns it into plain-English answers. Need the footnote that reconciles BTC holdings? Our engine flags it. Curious about board incentives? The Semler Scientific proxy statement executive compensation section is highlighted automatically. Real-time alerts cover Semler Scientific Form 4 insider transactions real-time and summarize each trade, while one-click views join every Semler Scientific 8-K material events explained with context. Here’s what you’ll find:
- Semler Scientific annual report 10-K simplified—AI extracts QuantaFlo revenue, R&D spend and bitcoin valuation swings.
- Instant dashboards for Semler Scientific insider trading Form 4 transactions and executive buying patterns.
- Concise tables that power Semler Scientific earnings report filing analysis across sequential quarters.
- Full text search, tagging and export for auditing or modelling.
Professionals use these insights to monitor reimbursement risk, gauge PAD market penetration, or track digital-asset strategy without reading each footnote. Whether you’re understanding Semler Scientific SEC documents with AI, reviewing Semler Scientific executive stock transactions Form 4, or studying supply-chain commentary, Stock Titan keeps you ahead of the next disclosure—no manual parsing required.
Semler Scientific, Inc. (SMLR) – Form 4 Overview
Director Natalie Brunell reported the grant of a single derivative security on 25 June 2025. The filing covers a stock option to purchase 1,125 shares of common stock at an exercise price of $41.04 per share. The instrument is classified as an acquisition (transaction code “A”).
Vesting schedule: 1/6 of the option (≈188 shares) vested immediately on the grant date, with the remaining 5/6 vesting in equal monthly tranches, resulting in full vesting six months after 25 June 2025. The option expires on 25 June 2035.
Post-transaction holdings: Ms. Brunell now beneficially owns 1,125 derivative securities directly. No non-derivative (outright share) transactions were reported.
No 10b5-1 trading plan was indicated, and no other insider participated in this filing. The grant appears to be a routine director compensation award and does not include any immediately exercisable common-stock sales or purchases.
Semler Scientific (Nasdaq:SMLR) filed a Form 8-K to report that on June 22, 2025 its board adopted Fifth Amended and Restated Bylaws, effective immediately.
According to Item 5.03, the revisions are limited to two governance housekeeping items: (i) removal of Section 13 to eliminate any ambiguity with Delaware General Corporation Law §228 (shareholder written consents) and (ii) revision of Section 47 so that the bylaws fully harmonize with the company’s certificate of incorporation. No changes were made to the fiscal year, capital structure, or shareholder voting thresholds.
The full text of the updated bylaws is provided as Exhibit 3.1. Other than the technical governance clean-up, the filing contains no financial statements, forward-looking guidance, or other material events. The document was signed by Chief Financial Officer Renae Cormier on June 23, 2025.
Semler Scientific, Inc. (Nasdaq: SMLR) filed an 8-K to disclose a major shift in its treasury policy. On 19 June 2025 the company appointed Joe Burnett as Director of Bitcoin Strategy and outlined an aggressive three-year plan to accumulate Bitcoin using a combination of equity offerings, debt financings and operating cash flow.
- Accumulation targets: at least 10,000 BTC by 31-Dec-2025, 42,000 BTC by 31-Dec-2026 and 105,000 BTC by 31-Dec-2027.
- Funding sources: prospective sales of securities, borrowings and internal cash generation.
- Governance: Burnett will oversee execution and risk management of the Bitcoin treasury strategy.
The filing contains extensive forward-looking statements highlighting material risks, including Bitcoin price volatility, execution risk in raising capital, leverage concerns and uncertainties related to the company’s proposed DOJ settlement. Management makes no commitment to update projections.
Investment view: The move could materially increase balance-sheet optionality if Bitcoin appreciates, but exposes shareholders to significant market and financing risk. The 8-K carries no immediate financial results or guidance changes.
FAQ
What is the current stock price of Semler Scientific (SMLR)?
What is the market cap of Semler Scientific (SMLR)?
